Entry |
|
Name |
Edatrexate (USAN/INN) |
Formula |
C22H25N7O5
|
Exact mass |
467.1917
|
Mol weight |
467.48
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG02018 Antimetabolite
DG01978 Folic acid analog
DG01930 Dihydrofolate reductase inhibitor
|
Efficacy |
Antineoplastic, Antimetabolite |
Target |
|
Pathway |
|
Interaction |
|
Other map |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01978 Folic acid analog
DG01930 Dihydrofolate reductase inhibitor
D03942 Edatrexate
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Dihydrofolate reductase
DHFR
D03942 Edatrexate (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8y C 22.8200 -18.2700
2 C8y C 22.8200 -16.8700
3 N5x N 24.0800 -18.9700
4 C8y C 21.6300 -18.9700
5 N5x N 24.0800 -16.1700
6 N5x N 21.6300 -16.1700
7 C8y C 25.3400 -18.2700
8 N5x N 20.5100 -18.2700
9 N1a N 21.6300 -20.3700
10 C8x C 25.3400 -16.8700
11 C8y C 20.5100 -16.8700
12 C1b C 26.5300 -18.9700
13 N1a N 19.3200 -16.1700
14 C1c C 27.7200 -18.2700
15 C1b C 27.7200 -16.9400
16 C1a C 28.9800 -16.2400
17 C8y C 28.9800 -18.9700
18 C8x C 28.9800 -20.4400
19 C8x C 30.1700 -21.1400
20 C8y C 31.4300 -20.3700
21 C8x C 31.4300 -18.9700
22 C8x C 30.1700 -18.2700
23 C5a C 32.6200 -21.0700
24 N1b N 33.8100 -20.4400
25 O5a O 32.6200 -22.5400
26 C1c C 34.9300 -21.1400
27 C1b C 36.1900 -20.5100
28 C1b C 37.3800 -21.2800
29 C6a C 35.0000 -22.6100
30 O6a O 33.7400 -23.2400
31 O6a O 36.1200 -23.3100
32 C6a C 38.6400 -20.5800
33 O6a O 39.8300 -21.3500
34 O6a O 38.7100 -19.2500
BOND 36
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 2
7 4 8 2
8 4 9 1
9 5 10 2
10 6 11 2
11 7 12 1
12 11 13 1
13 12 14 1
14 7 10 1
15 8 11 1
16 14 15 1
17 15 16 1
18 14 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 17 22 1
25 20 23 1
26 23 24 1
27 23 25 2
28 24 26 1
29 26 27 1
30 27 28 1
31 26 29 1 #Up
32 29 30 2
33 29 31 1
34 28 32 1
35 32 33 1
36 32 34 2
|